|
Please note
that NIH has published changes to the NIH’s Grant Appendix Policy, effective January
25, 2017 (NOT-OD-16-129).
The updated appendix policy eliminates most items that investigators previously
included in the application appendix. Elimination of most Appendix
materials is intended to rectify inequities in the peer review process that can
arise from submission of inappropriate or excessive Appendix materials by some
applicants and consideration of Appendix materials in peer review by some, but
not all reviewers. Applications will be withdrawn and not reviewed if
they are submitted with inappropriate appendix materials. This policy is
relevant for all funding mechanisms, including SBIR and STTR applications.
For more information read the full Notice NOT-OD-17-035 and view the Frequently Asked Questions Document at FAQs.
Submit your application to the business plan competition for a chance to be named the company with the most commercial potential at the Regional Biotech Forum. Prizes include the opportunity to win $10,000 and an incubation space! Pitch your idea to industry experts on April 20th. Five Finalists will have the chance to win the grand prize. This competition will be focused on companies in the following sectors: therapeutics, diagnostics, medical devices, healthcare services, e-health, mobile health, electronic medical records, health informatics, and biohealth cyber security.
Companies will be scored on: product, technical feasibility, marketing/strategy, and leadership team.
Finalists will be announced by April 6th
Regional Biotech Forum Event event panel presentation is on April 20th
For more information, please visit:
BioHealth Innovation
crabtrap.regionalbiotechforum.com
The next NIH Small Business Innovation Research (SBIR) and Small
Business Technology Transfer (STTR) Omnibus funding opportunity deadline is
only weeks away on April 5, 2017. The National Heart, Lung, and
Blood Institute (NHLBI) welcomes all investigator-initiated projects within our
mission through these funding opportunities:
Learn about the NHLBI Mission
Additional Funding Opportunities Expiring
- Exp. April 6, 2017: Phase II Awardees - Commercialization
Readiness Pilot (CRP) Program: Technical Assistance ( PAR-16-026,
Notice about NHLBI participation NOT-HL-15-283)
-
Exp. Jan. 8, 2018: New Technologies for Viral
Hepatitis (SBIR
PA-15-077
STTR PA-15-076)
View all NHLBI Targeted Funding Opportunities on our website.
Get Ready
Contact us at NHLBI_SBIR@mail.nih.gov
for advice and assistance.
Seek NHLBI guidance while writing your Bridge
and Small Market Applications
Apply for up to $3M to
support continued development of your Phase II SBIR or STTR-funded heart, lung,
blood, or sleep technology requiring approval or clearance by a Federal
regulatory agency. The National Heart, Lung, and Blood Institute (NHLBI) SBIR Phase IIB Bridge
and Small Market Awards programs aim to de-risk your technology and encourage partnerships
between small businesses and investors and strategic partners.
Letters of Intent due May 19, 2017.
Applications due June 19, 2017.
For more information, please read the full Notice:
Wednesday, March 22
1:00 - 2:30PM ET
Registration is not necessary, JOIN the webinar HERE
The FDA is hosting a
webinar for developers and sponsors of neurological devices on the De Novo
pathway, an alternate pathway to classify novel devices automatically placed in
Class III after receiving a "not substantially equivalent" (NSE)
determination in response to a premarket notification [510(k)] submission.
This webinar will provide:
- An introduction to the
FDA’s role in facilitating innovation in neurological device technology
- An overview of the De
Novo classification process
- Information on working
with the FDA and the pre-submission process
Conference number: PW3106674
Audience passcode: 1891131
For more information, please check out the FDA's website: HERE
Two recently delivered NHLBI Small Biz Hangouts have been posted on YouTube to our full playlist. Please check them out!
Taking Care of Business: Managing SBIR/STTR Grants
This NHLBI Small Biz Hangout addresses the business aspects
of managing an NIH Small Business Innovation Research/Small Business Technology
Transfer (SBIR/STTR) grant, explaining the Just-In-Time (JIT) process to
provide information required before awards can be made; when you need to get
approval from NIH for changes to your project; and common myths and
misconceptions about the SBIR/STTR grants process.
Perfecting Your Pitch
Perfecting your pitch or a new medical product, it’ll save lives, speed recovery,
be less expensive, more accurate and durable than the product already available
on the market – or it may fill a gap where there is no product available. You
have an experienced team, strong IP, an understanding of the regulatory and
reimbursement coverage data requirements – all you need to get to market is
MORE MONEY! In this Small Biz Hangout one of NHLBI’s funded companies will
demonstrate how to deliver a strong pitch to investors and our
Investor-in-Residence will comment on the most effective and impactful aspects
of the delivery.
03/17 – 03/19 – American College of Cardiology (ACC. 17) –
Washington, DC
03/23 –
3/25 - Venture Well – Washington, DC
03/30 –
3/31 - AdvaMed Innovation Summit – Washington,
DC
|
